This is great progress in the field of stem cells. Japan will be the first to try this on a patient. We wish them great sucess with this procedure. – MDA
Tokyo: A Japanese patient with a debilitating eye disease will be the first person in the world to be treated with the next-generation stem cells called induced pluripotent stem (iPS) cells.
The technique, which has earned its inventor a Nobel Prize, will now be used to treat a Japanese man suffering from age-related macular degeneration, a debilitating eye disease.
According to the scientific journal Nature, a 19-member health ministry committee has vetted the researchers’ safety tests and cleared the team to begin the experimental procedure.
Masayo Takahashi, an ophthalmologist at the RIKEN Center for Developmental Biology (CDB) in Kobe has been using induced pluripotent stem (iPS) cells to prepare a treatment for age related macular degeneration.
 During her research on mice and monkeys, Takahashi took skin cells from people with the disease and converted them to iPS stem cells.  
She then coaxed these cells to become retinal pigment epithelium cells and then to grow into thin sheets that can be transplanted onto the damaged retina.
In monkey studies, iPS cells generated…
Read more: http://zeenews.india.com/news/health/diseases-conditions/induced-stem-cells-cleared-for-human-trial-in-japan_1468434.html
 
source: Zee News

On